Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients

Fabrice Lainé, Marc Ruivard, Véronique Loustaud‐Ratti, Fabrice Bonnet, Paul Calès, Edouard Bardou‐Jacquet, Sylvie Sacher‐Huvelin, Xavier Causse, Christine Beusnel, Alain Renault, Eric Bellissant, Yves Deugnier, Study Group – 29 September 2016 – Dysmetabolic iron overload syndrome (DIOS) is a common cause of hyperferritinemia, accounting for a mild increase of iron stores in insulin‐resistant subjects. Iron removal could improve insulin sensitivity.

Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B

Jenny Yeuk‐Ki Cheng, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Angel Mei‐Ling Chim, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong – 29 September 2016 – Metabolic syndrome is an independent risk factor of liver cirrhosis in chronic hepatitis B (CHB). Whether metabolic syndrome affects the long‐term prognosis of CHB patients in terms of hepatic events, cardiovascular events, and death remains unknown. We aimed to determine the incidences of hepatic events, cardiovascular events, and death in CHB patients with or without metabolic syndrome.

Liver injury from herbal and dietary supplements

Victor J. Navarro, Ikhlas Khan, Einar Björnsson, Leonard B. Seeff, Jose Serrano, Jay H. Hoofnagle – 27 September 2016 – Herbal and dietary supplements (HDS) are used increasingly both in the United States and worldwide, and HDS‐induced liver injury in the United States has increased proportionally. Current challenges in the diagnosis and management of HDS‐induced liver injury were the focus of a 2‐day research symposium sponsored by the American Association for the Study of Liver Disease and the National Institutes of Health.

Liver injury from herbal and dietary supplements

Victor J. Navarro, Ikhlas Khan, Einar Björnsson, Leonard B. Seeff, Jose Serrano, Jay H. Hoofnagle – 27 September 2016 – Herbal and dietary supplements (HDS) are used increasingly both in the United States and worldwide, and HDS‐induced liver injury in the United States has increased proportionally. Current challenges in the diagnosis and management of HDS‐induced liver injury were the focus of a 2‐day research symposium sponsored by the American Association for the Study of Liver Disease and the National Institutes of Health.

Subscribe to